Virtual Exhibit Hall
Premier Partner: AbbVie
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world's most complex and critical conditions. The company's mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook or LinkedIn.
At Pfizer Oncology, we are committed to advancing medicines wherever we believe we can make a meaningful difference in the lives of people living with cancer. Today, we have an industry-leading portfolio of 23 approved innovative cancer medicines and biosimilars across more than 30 indications, including breast, prostate, kidney, colorectal, blood and lung cancers, as well as melanoma.
Pfizer Oncology's This Is Living With Cancer™ program and the free LivingWith® app
This Is Living With Cancer is a program that includes resources designed for all people living with cancer, regardless of tumor type or stage of disease. This program is available to anyone in the United States, whether they're currently on a Pfizer treatment or not.
An important feature of the program is LivingWith, a free app for people living with cancer and those who love them. LivingWith is designed to help patients connect with loved ones, ask for the help they need, remember important information from doctors' visits and stay organized, all in one place.
LivingWith helps with the small details so patients can focus on the big picture. It's available in English and Spanish.
Website: LivingWith App Website: Know Your Prostate Plan
Learn more about a treatment option for prostate cancer that is no longer responding to hormone therapy* and has not spread to other parts of the body.
Learn more about a treatment option for prostate cancer that is no longer responding to hormone therapy* and has spread to the bone with symptoms but not to other parts of the body.
*Hormone therapy includes gonadotropin releasing hormone (GnRH) or surgery that lowers testosterone.
Contact the Men's Health Patient Education team for more information:
MHpatienteducation@bsci.com or 844-433-2873
Contact the Men's Health Patient Education team for more information:
MHpatientEducation@bsci.com or 844-433-2873
Contact the SpaceOAR Patient Education team for more information:
firstname.lastname@example.org or 508-202-4168
At Tolmar, science drives everything we do. Through a relentless focus on technology, science, partnership and excellence, we seek to advance patient care and deliver value through innovative therapies and services.
Daughters 4 Dads
Martin-O’Neil Cancer Center is one of the region’s most respected centers devoted to cancer patient care, research, education and prevention. Located in the beautiful Napa Valley, our staff takes pride in providing a multidisciplinary approach to treatment, which brings together teams of experts including surgeons, medical oncologists, radiation therapists and other cancer subspecialists to collaborate on the best treatment plan that’s right for you. We are proud to partner with ZERO to support prostate cancer prevention and treatment in our community.
Amgen is a worldwide pioneer in biotechnology. Our mission is to serve patients. We are proud of our heritage as a biotech startup, our people, our culture, our dedication to our mission and always doing the right thing in everything we do through corporate responsibility it’s what makes Amgen a great and special place to work. Together, we transform how patients, physicians, caregivers and societies around the world fight serious illnesses and high unmet medical need. We discover, develop and deliver transformative medicines that address the leading causes of death and disability and we find new solutions to meet the growing demand for better quality healthcare for more people worldwide.Visit Our Website
Optum Specialty is a leading specialty pharmacy services company dedicated to helping administer and deliver high-quality, cost-effective specialty pharmacy care. Optum Specialty Pharmacy combines technology, data and expertise to provide educational resources, 24/7 pharmacy support and trusted advice to the individuals, caregivers and care teams we serve.Visit Our Website Download Flyer (PDF)
Where expertise and dedication join forces. Philanthropy is ingrained in my life. Mention this ad and I will dedicate 15% of my commissions to ZERO Prostate Cancer, a cause near and dear to my heart. email@example.com | (707) 280-1917Visit My Facebook Page
For over 25 years the Marin Prostate Cancer Support Group has been providing an environment for the exchange of information and support to hundreds of prostate cancer patients from newly diagnosed patients to patients with advanced disease.
Visit Our Website Download Flyer (PDF)
HALO Diagnostics is a very different kind of healthcare company. Headquartered in Silicon Valley, CA, HALO Diagnostics leverages cutting-edge artificial intelligence and machine learning, along with the latest in advanced imaging and diagnostic biomarkers to deliver more holistic diagnostic insights and significant improvement in patient experience and outcomes.
Thanks to advances in technology, many of today’s most devastating diseases can be diagnosed earlier and more accurately, and then treated less invasively and without surgery. HALO Diagnostics believes that advanced technology can help deliver a better patient experience with a more personalized touch. At the core of the practice is an array of advanced imaging technologies—used to both diagnose disease and guide treatment. Early detection of disease enables a broader assortment of treatment options, and HALO offers several minimally invasive therapies that are just as effective as traditional surgery, with less risk and a shorter recovery period.
The specialized team at HALO Diagnostics have pioneered a new approach to prostate cancer treatment, Laser Focal Therapy. HALO recently released interim 10-year results from its Phase II 20-year clinical trial for prostate laser focal therapy in patients with localized prostate cancer. The results are impressive: less than 1% infection, less than 1% erectile dysfunction and less than 1% incontinence. These results, along with a 100% prostate cancer-specific survival rate, are an encouraging development for men looking for a prostate cancer therapy option with a lower risk of side effects.
The prostate program is just one step in helping fulfill HALO Diagnostics’ mission of improving human health and well-being via local and easy access to advanced diagnostics and image-guided therapy options. For more information visit www.halodx.com and follow LinkedIn and Facebook to stay up to date with all things HALO Dx.
Visit Our Website